Best Lymphangioma doctors in Istanbul: TOP 8 doctors

Dr. Mustafa Solak specializes in breast, lung, and gastrointestinal cancers at Hisar Hospital Intercontinental, with training at Hacettepe University and MD Anderson Cancer Center.

• Completed fellowship in oncological surgery
• Extensive experience treating head and neck cancers
• Worked at top-tier institutions including MD Anderson Cancer Center
• Specializes in minimally invasive oncology procedures

Dr. Yildiz has published extensively on rare endocrine and neuroendocrine tumors, with research featured in international medical journals.

• Specializes in complex neuroendocrine tumor cases
• Authored 17+ peer-reviewed publications on rare tumors
• Works at Medipol Mega University Hospital – a leading research center
• Focuses on multidisciplinary approaches to tumor management

Prof. Sezer Sağlam specializes in Lymphangioma treatment, bringing 30+ years of oncology experience to Gayrettepe Florence Nightingale Hospital.

• Professor since 2016 with focus on medical oncology
• Trained at Istanbul University's renowned oncology institute
• Member of ESMO, ASCO & European Neuroendocrine Tumor Society
• Former attending physician in gastrointestinal oncology

Dr. Tahsin Ozadli specializes in medical oncology with a focus on complex cancer cases at Valued Med Hub Hospitals.

• Trained at Ankara Oncology Training and Research Hospital
• Experience in lung, esophageal, gastric, and breast cancers
• Works with gastrointestinal surgery cases
• Published research available on Google Scholar

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor of Medical Oncology with over 20 years of experience – Dr. Saglam specializes in gastrointestinal oncology at Istanbul Florence Nightingale Hospital.

• Fellowship-trained at Istanbul University Oncology Institute
• Member of ESMO, ASCO, and ENET
• Focuses on advanced treatment protocols for complex cases

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.